BEIJING, Aug. 13 /Xinhua-PRNewswire-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People's Republic of China ("PRC"), today announced that it will conduct a conference call at 10:00 a.m. Eastern Time on Monday, August 18, 2008 to discuss results for the quarter ended June 30, 2008.
Joining Dr. Zhongyi Liu, Chairman and Chief Executive Officer of Lotus Pharmaceuticals, will be Mr. Adam Wasserman, Chief Financial Officer.
To participate in this live conference call, please dial 888-481-7939 five to ten minutes prior to the scheduled conference call time. International callers should dial 617-847-8707. The conference Passcode is 306 650 22.
For those who are unable to participate in the conference call at the time of the call, a replay will be available for fourteen days starting on August 18, at 12:00 p.m. Eastern Time. To access the replay, please dial 888-286- 8010. International callers should dial 617-801-6888. The replay Passcode is 939 152 01.
About Lotus Pharmaceuticals, Inc.
Lotus Pharmaceuticals, Inc. controls and operates Liangfang Pharmaceutical Company, Ltd. ("Liang Fang") and En Ze Jia Shi Pharmaceutical Company, Ltd. ("En Ze"), two pharmaceutical companies located in Beijing, China. Together, Liang Fang and En Ze form an operating company (together, "Lotus East"). Lotus East engages in the development of new drugs, drug manufacturing, and the marketing and sales of pharmaceuticals. Lotus East has advanced pharmaceutical production equipment with which it produces a portfolio of pharmaceutical products, and meets National GMP. Lotus East has a number of highly skilled scientists, 2,000 square meters of office space and a 1,000 square meter warehouse. It operates ten retail pharmacies in the Beijing area.
Safe Harbor Statement
This press release contains "forward-looking statements" within the
meaning of the "safe-harbo
|SOURCE Lotus Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved